iifl-logo

Marksans Pharma Ltd Historical Data

227.75
(-1.66%)
Jul 25, 2025|12:00:00 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Marksans Pharma Ltd Historical Data

26/06/2025calendar-icon
26/07/2025calendar-icon
Date
Open(₹)
High(₹)
Low(₹)
Close(₹)
No. Of Trades(₹)
Total Turnover(₹)
Deliverable Quantity(₹)

26-Jun-2025

248.1

250.95246.1247.0513,16419,14,45,744.454,07,344

27-Jun-2025

248

255.35246.9252.5517,02623,62,32,150.84,46,103

30-Jun-2025

253.4

263.85252.7261.528,28641,90,03,512.955,47,988

01-Jul-2025

263.55

263.95257.15258.513,27217,02,00,632.62,86,610

02-Jul-2025

258

260.55256257.359,65612,20,31,439.452,21,366

03-Jul-2025

258.2

261.6257.15259.515,15919,53,09,546.22,95,506

04-Jul-2025

260.05

265256.5263.0521,02028,29,10,699.54,29,039

07-Jul-2025

263.3

266.6256.4257.418,10423,38,67,243.253,71,922

08-Jul-2025

257.5

258.85249.5252.4520,16125,31,22,772.754,89,481

09-Jul-2025

253.05

261252.8258.8520,96527,82,74,576.053,85,466

10-Jul-2025

259

260.95255256.759,95311,97,59,741.42,16,085

11-Jul-2025

256.95

266253.5254.5522,09432,23,38,130.94,62,648

14-Jul-2025

255

265251.3260.628,49742,15,03,378.458,04,896

15-Jul-2025

261

265.5259.55261.3512,66620,02,30,673.63,48,154

16-Jul-2025

261.35

264.7259.25261.0513,52616,74,05,197.33,24,730

17-Jul-2025

261.05

266.5257258.916,68619,76,25,644.92,93,896

18-Jul-2025

259.55

260.8255.15255.758,68410,37,67,914.151,68,896

21-Jul-2025

255

255.55246.3247.5517,99024,45,35,047.555,52,858

22-Jul-2025

248.4

250.5241.2242.0521,64327,55,17,992.256,14,646

23-Jul-2025

242.8

244.1236.3237.221,37029,31,86,442.36,48,394

24-Jul-2025

238.15

242.45230.3231.633,19751,92,19,346.612,16,837

25-Jul-2025

231.6

233.45226.1227.7523,58140,02,12,440.259,84,004

Marksans Pharma: Related NEWS

Marksans Pharma Secures EIR from USFDA for Subsidiary’s New York Facility
30 Jun 2025|05:57 PM

The inspection by the USFDA had taken place between April 16 and 24. After the visit, the company disclosed one observation under Form 483.

Read More
OrbiMed to Offload 2.27% Stake in Marksans Pharma via Block Deal
11 Jun 2025|12:34 PM

The block deal has been launched at a floor price of ₹249.95 per share, signaling a strategic partial exit by the investor.

Read More
Marksans Pharma’s Relonchem Gets UK MHRA Approval for Baclofen 10 mg
21 Mar 2025|12:02 PM

Relonchem Ltd has secured Marketing Authorisation from the UK Medicines and Healthcare Products Regulatory Agency (MHRA) for Baclofen 10 mg Tablets

Read More
Marksans Pharma gets USFDA approval for anti-allergy drug
22 Nov 2024|02:54 PM

The US Food and Drug Administration (FDA) approved the pharmaceutical company's Abbreviated New Drug Application (ANDA) for Loratadine Tablets USP 10 mg.

Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.